AnalystsElemer PirosElemer Piros's Stock Forecasts
AnalystsElemer Piros
Analyst Ranking
Bottom 3%
#4104 out of 4227 analysts
Average Return
-11.43%
Win Rate
30%25 out of 82
Risk vs Reward
Poor
Good
Elemer Piros's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arrowhead Pharmaceuticals IncARWR | +371.70% | $13.96 | $65.85 | 2018-12-17 - 2019-12-17 | Strong Buy |
Krystal Biotech IncKRYS | +127.48% | $21.00 | $47.77 | 2018-09-11 - 2019-09-11 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +116.11% | $9.00 | $19.45 | 2018-05-09 - 2019-05-09 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +89.12% | $33.66 | $63.65 | 2020-07-20 - 2021-07-19 | Strong Buy |
Aldeyra Therapeutics IncALDX | +71.41% | $6.40 | $10.97 | 2017-10-25 - 2018-10-25 | Strong Buy |
Elemer Piros Analyst Color
Get additional color on Elemer Piros's coverage of popular stocks
Elemer Piros's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mind Medicine IncMNMD | 6 | Strong Buy | $21.00 | +494.06% | Reiterates | 13 days ago |
Unicycive Therapeutics IncUNCY | 4 | Strong Buy | $5.00 | +270.37% | Reiterates | 14 days ago |
Coya Therapeutics IncCOYA | 3 | Strong Buy | $28.00 | +540.73% | Reiterates | 14 days ago |
Opthea LtdOPT | 2 | Strong Buy | $23.00 | +603.36% | Reiterates | 15 days ago |
Compass Pathways PLCCMPS | 5 | Strong Buy | $38.00 | +396.73% | Reiterates | 19 days ago |
Atai Life Sciences NvATAI | 6 | Strong Buy | $15.00 | +747.46% | Reiterates | 2 months ago |
Monopar TherapeuticsMNPR | 5 | Strong Buy | $17.00 | +1,753.87% | Maintains | 2 months ago |
Clene IncCLNN | 5 | Strong Buy | $13.00 | +1,278.58% | Reiterates | 2 months ago |
Gh Research PLCGHRS | 3 | Strong Buy | $33.00 | +200.00% | Reiterates | 3 months ago |
Cybin IncCYBN | 2 | Strong Buy | $3.00 | +927.40% | Reiterates | 3 months ago |
Reunion Neuroscience IncREUN | 2 | Strong Buy | $11.00 | +1,471.43% | Reiterates | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 6 | Strong Sell | $40.00 | N/A | Downgrades | a year ago |
Unity Biotechnology IncUBX | 3 | Strong Buy | $40.00 | N/A | Upgrades | a year ago |
Biorestorative Therapies IncBRTX | 1 | Strong Buy | $37.00 | N/A | Initiates Coverage On | a year ago |
Diamedica Therapeutics IncDMAC | 2 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Global Blood Therapeutics IncGBT | 5 | Strong Buy | $124.00 | N/A | Maintains | 2 years ago |
Durect CorpDRRX | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 3 years ago |
Cohbar IncCWBR | 1 | Strong Buy | $240.00 | N/A | Initiates Coverage On | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | $77.00 | N/A | Reinstates | 3 years ago |
Polarityte IncPTE | 2 | Strong Buy | $75.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 3 | Strong Buy | $191.00 | N/A | Reiterates | 4 years ago |
Spark Therapeutics IncONCE | 2 | Hold | $114.50 | N/A | Downgrades | 4 years ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Strong Buy | $165.00 | N/A | Maintains | 4 years ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 5 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 4 | Strong Buy | $1,080.00 | N/A | Maintains | 5 years ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Strongbridge Biopharma PLCSBBP | 2 | Strong Buy | $17.00 | N/A | Maintains | 5 years ago |
Corner Growth Acquisition CorpCOOL | 1 | Strong Buy | $65.00 | N/A | Maintains | 5 years ago |
Dynavax Technologies CorpDVAX | 2 | Strong Buy | $250.00 | N/A | Maintains | 6 years ago |
Aldeyra Therapeutics IncALDX | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 6 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $850.00 | N/A | Maintains | 6 years ago |
Ocular Therapeutix IncOCUL | 1 | Strong Buy | $21.00 | N/A | Maintains | 6 years ago |
Omeros CorpOMER | 1 | Hold | $15.00 | N/A | Downgrades | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.